1.
Nalamachu, MD SR, Parikh N, Dillaha, MD L, Rauck, MD R. Lack of correlation between the effective dose of fentanyl sublingual spray for breakthrough cancer pain and the around-the-clock opioid dose. J of Opioid Management [Internet]. 2014 Jul. 1 [cited 2024 Nov. 21];10(4):247-54. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/79